new england journal of medicine semaglutide Cardiac Trials | ~~ Most popular trial post #2023 ~~ GLP1 agonism in overweight/obese patients to reduce cardiovascular mortality? This landmark trial In the SURMOUNT-5 phase 3b

Mokgalaboni K (2025) Exploring the anti-inflammatory potential of vitamin D in cardiometabolic diseases

Understanding how these medications affect your body composition and skin elasticity is crucial for making informed decisions about potential body contouring procedures

For example, if someone has an inherited issue like the Factor V Leiden mutation, the chance of clotting can go up a lot

5) Solara Active Pharma - The Turnaround in Progress, Dragged by Ibuprofen Solaras story in Q4 FY26 is a tale of two businesses running in opposite directions

Ozempic changes your appetite, which can lead to a nutrient shortage

Ferroptosis: An iron-dependent form of nonapoptotic cell death